Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app help liver transplant patients recover faster?

NCT ID NCT07530913

Disease control Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a digital rehabilitation platform helps people recover after a living donor liver transplant. 36 adults will be split into two groups: one gets the digital program plus standard education, the other gets standard education only. Researchers will measure physical function, muscle strength, and quality of life before surgery and up to 3 months after discharge.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital rehabilitation exercise platform
What this could lead to
If it works, this could offer a convenient way for liver transplant patients to recover strength and function at home using a digital tool.
What could go wrong
This is a small, early-stage trial with only 36 participants. The digital platform may not significantly improve recovery compared to standard education alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients undergoing living donor liver transplantation who require continuous rehabilitation treatment * Adults aged 20 to 65 years * Able to independently operate digital devices such as a smartphone or tablet PC * Able to perform exercises and review feedback using the digital rehabilitation platform * No significant impairment in hearing, vision, or cognitive function that would interfere with understanding audio and visual instructions provided by the platform Exclusion Criteria: * Patients with an inadequate level of consciousness or cognitive impairment making cooperation with the rehabilitation exercise program difficult * Patients who have difficulty using digital devices or cannot independently use digital-based services * Patients with severe limitations in muscle strength or range of motion, or amputation-related disability, making the exercise program difficult to perform * Patients who require restriction of movement necessary for the rehabilitation exercise program due to fracture or musculoskeletal instability * Patients with pain during upper or lower extremity movement and biomechanical instability that makes participation difficult * Patients with visual or hearing impairment that interferes with cooperation in the rehabilitation exercise program * Patients who develop medical complications or transplant rejection during study participation * Patients unable to perform physical activity because of abdominal pain

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Liver transplantation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Liver transplantation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Samsung Medical Center

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.